- Home
- WLKP vs AVBP Comparison
WLKP vs AVBP Comparison
Compare WLKP & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- AVBP
- Stock Information
- Founded
- WLKP 2014
- AVBP 2021
- Country
- WLKP United States
- AVBP United States
- Employees
- WLKP N/A
- AVBP N/A
- Industry
- WLKP Major Chemicals
- AVBP
- Sector
- WLKP Industrials
- AVBP
- Exchange
- WLKP Nasdaq
- AVBP NYSE
- Market Cap
- WLKP 819.6M
- AVBP 925.7M
- IPO Year
- WLKP 2014
- AVBP 2024
- Fundamental
- Price
- WLKP $24.07
- AVBP $25.31
- Analyst Decision
- WLKP
- AVBP Strong Buy
- Analyst Count
- WLKP 0
- AVBP 5
- Target Price
- WLKP N/A
- AVBP $36.80
- AVG Volume (30 Days)
- WLKP 38.9K
- AVBP 151.8K
- Earning Date
- WLKP 02-18-2025
- AVBP 02-02-2025
- Dividend Yield
- WLKP 7.81%
- AVBP N/A
- EPS Growth
- WLKP 8.66
- AVBP N/A
- EPS
- WLKP 1.75
- AVBP N/A
- Revenue
- WLKP $1,143,109,000.00
- AVBP N/A
- Revenue This Year
- WLKP N/A
- AVBP N/A
- Revenue Next Year
- WLKP $5.56
- AVBP N/A
- P/E Ratio
- WLKP $13.78
- AVBP N/A
- Revenue Growth
- WLKP N/A
- AVBP N/A
- 52 Week Low
- WLKP $21.19
- AVBP $14.35
- 52 Week High
- WLKP $24.34
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- WLKP 66.81
- AVBP 43.45
- Support Level
- WLKP $22.84
- AVBP $23.63
- Resistance Level
- WLKP $23.99
- AVBP $26.54
- Average True Range (ATR)
- WLKP 0.33
- AVBP 1.53
- MACD
- WLKP 0.10
- AVBP -0.10
- Stochastic Oscillator
- WLKP 90.65
- AVBP 34.46
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.